| Literature DB >> 30662484 |
Michael Kogan1, Robert Klempfner2, Dor Lotan1, Yishay Wasserstrum1, Ilan Goldenberg2, Gad Segal1.
Abstract
BACKGROUND/Entities:
Keywords: ALT (alanine aminotransferase); Cardiac rehabilitation; Ergometry; Fitness; Frailty; METS (metabolic equivalent of tasks)
Year: 2017 PMID: 30662484 PMCID: PMC6323158 DOI: 10.1016/j.jesf.2017.11.002
Source DB: PubMed Journal: J Exerc Sci Fit ISSN: 1728-869X Impact factor: 3.103
Baseline characteristics of the whole study cohort.
| P value | ALT ≥17 IU | ALT <17 IU | N | |
|---|---|---|---|---|
| 2470 | 1336 | |||
| Patients demographics | ||||
| NS | 61 | 64 | Age (years, mean) | |
| P < 0.001 | 474 (19.2%) | 402 (30.1%) | Female [n (%)] | |
| 0.06 | 27.2 ± 4 | 27.8 ± 4 | BMI (±SD) | |
| Background diagnosis | ||||
| P < 0.05 | 667 (27%) | 422 (31.6%) | Diabetes Mellitus [n (%)] | |
| P < 0.001 | 1833 (74.2%) | 900 (67.4%) | IHD | |
| P < 0.001 | 1803 (73%) | 935 (70%) | Past MI | |
| P = 0.001 | 73 (3.0%) | 70 (5.2%) | COPD | |
| P < 0.05 | 1233 (49.9%) | 727 (54.4%) | Hypertension | |
| P = 0.052 | 311 (12.6%) | 199 (14.9%) | CHF | |
| P = 0.324 | 1325 (53.6%) | 694 (51.9%) | Dyslipidemia | |
| P = 0.091 | 74 (3.0%) | 54 (4.0%) | PVD | |
| P = 1 | 208 (8.4%) | 113 (8.5%) | Active Smoking | |
| P = 0.709 | 48.3% | 47.7% | LVEF < 50% | |
| 0.44 | 198 (8%) | 94 (7%) | Valve surgery | |
| NS | 17.8% | 16.5% | I | NYHA |
| 5.3% | 5.9% | II | ||
| 3.2% | 5.2% | IIIA | ||
| 0.9% | 1.2% | IIIB | ||
| 0.2% | 0.1% | IV | ||
| Laboratory values | ||||
| 0.14 | 69 | 70 | eGFR ml/min/1.73 m2 | |
| NS | 13.1 | 13.56 | Hb (gr/dL) | |
| Medications | ||||
| P = 0.309 | 78.5% | 76% | ARB or ACE-I | |
| P = 0.548 | 70.3% | 69.5% | Beta Blockers | |
| 0.011 | 85% | 88% | Statins | |
| 0.13 | 82% | 86% | Platelet inhibitors | |
| P = 0.303 | 5.7% | 6.4% | Digitalis | |
| Stress test parameters | ||||
| <0.001 | 7.73 | 6.86 | METS value | |
| <0.001 | 07:44 | 06:41 | Test duration (min:sec) | |
| 0.01 | 70 ± 13 | 72 ± 13 | Resting heart rate (BPM) | |
| 0.01 | 124 ± 19 | 126 ± 24 | Resting SBP (mmHg) | |
| <0.001 | 54 ± 24 | 49 ± 24 | Heart rate reserve (BPM) | |
| 0.44 | 161 ± 27 | 164 ± 94 | Max SBP (mmHg) | |
COPD, Chronic Obstructive Pulmonary Disease; IHD, Ischemic Heart Disease; CHF, Congestive Heart Failure; NS, Non-Significant; PVD, Peripheral Vascular Disease; NYHA, New York Heart Association functional status; ACE-I, Angiotensin Converting Enzyme Inhibitors; ARB, Angiotensin Receptor blockers; LVEF, Left Ventricle Ejection Fraction; BPM, Beats Per Minute; SBP, Systolic Blood Pressure.
Patient characteristics found to be independent predictors for lower ALT activity.
| P value | 95%CI | OR | Covariate | |
|---|---|---|---|---|
| Upper | Lower | |||
| <0.001 | 2.20 | 1.60 | 1.87 | Female gender |
| 0.04 | 1.39 | 1.01 | 1.19 | Diabetes mellitus |
| <0.001 | 1.58 | 1.12 | 1.33 | Past CABG |
| 0.15 | 1.30 | 0.96 | 1.12 | Hypertension |
| 0.02 | 0.97 | 0.72 | 0.83 | Dyslipidemia |
| 0.68 | 1.35 | 0.82 | 1.05 | Smoker |
| 0.22 | 1.42 | 0.92 | 1.15 | Past Valve surgery |
| 0.11 | 1.06 | 0.59 | 0.79 | Cardiomyopathy |
| 0.00 | 2.41 | 1.21 | 1.70 | COPD |
| 0.70 | 1.17 | 0.79 | 0.96 | Atrial Fibrillation or flutter |
| 0.03 | 1.61 | 1.02 | 1.29 | Past CVA |
| 0.04 | 1.75 | 1.02 | 1.33 | LVEF <50% |
| 0.076 | 1.00 | 0.94 | 0.97 | BMI |
| 0.01 | 1.92 | 1.08 | 1.44 | Blood Creatinine concentration (per 1 mg/dL increment) |
| 0.04 | 0.99 | 0.57 | 0.75 | Past MI |
| <0.001 | 1.03 | 1.01 | 1.02 | Age (per year increment) |
A multivariate linear model for independent determinants of baseline exercise capacity (expressed in METs).
| p value | Coefficient | Covariate |
|---|---|---|
| <0.001 | 0.024 | ALT (IU/dl) |
| <0.001 | −0.117 | Age |
| <0.001 | 1.86 | Heart failure diagnosis |
| <0.001 | 0.204 | Hemoglobin g/dL |
| <0.001 | 0.024 | LVEF % |
| <0.001 | 1.202 | COPD diagnosis |
Introduced as continuous variables.